Pilopine Hs

Presbyopia, Miosis, laser eye surgery + 8 more

Treatment

20 Active Studies for Pilopine Hs

What is Pilopine Hs

Pilocarpine

The Generic name of this drug

Treatment Summary

Pilocarpine is a drug that helps treat glaucoma. It works by increasing the size of the pupil and reducing the pressure in the eye. It is not related to nicotine and works slowly when taken.

Isopto Carpine

is the brand name

image of different drug pills on a surface

Pilopine Hs Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Isopto Carpine

Pilocarpine

1974

62

Effectiveness

How Pilopine Hs Affects Patients

Pilocarpine is a medication that triggers the release of fluid from glands in the body, like sweat and saliva. When applied directly to the eye, it can cause the pupil to contract. It can also cause some temporary changes in blood pressure, as well as increased activity of the muscles in the intestines, lungs, and urinary and biliary systems. Pilocarpine can also have a strange effect on the heart, causing both a rapid heartbeat and a slow heartbeat in some cases.

How Pilopine Hs works in the body

Pilocarpine is a drug that stimulates certain nerve receptors in the body. When taken as an eye drop, it causes the muscles of the iris and ciliary to contract, leading to increased secretions from the glands.

When to interrupt dosage

The prescribed quantity of Pilopine Hs is contingent upon the diagnosed condition, including Open Angle Glaucoma, Miosis and laser eye surgery. The measure of dosage fluctuates as per the method of administration featured in the table below.

Condition

Dosage

Administration

Presbyopia

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Miosis

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

laser eye surgery

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Glaucoma, Open-Angle

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Radiotherapy

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Glaucoma

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Xerostomia

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Open Angle Glaucoma

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Ocular Hypertension

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Glaucoma, Angle-Closure

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Glaucoma

, 5.0 mg, 7.5 mg, 10.0 mg/mL, 40.0 mg, 1.0 %, 2.0 %, 4.0 %, 11.0 mg, 0.5 %, 6.0 %, 1.75 %, 20.0 mg/mL, 40.0 mg/mL, 2.5 mg/mL, 17.5 mg/mL, 0.04 mg/mg, 10.0 mg, 0.025 mg/mg, 5.0 mg/mL, 60.0 mg/mL, 12.5 mg/mL

, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Conjunctival, Solution / drops, Solution / drops - Conjunctival, Ophthalmic, Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic, Solution / drops - Ophthalmic, Implant, Implant - Intraocular, Intraocular, Gel, Gel - Ophthalmic, Suspension, Suspension - Ophthalmic, Kit, Topical, Kit - Ophthalmic, Kit - Topical

Warnings

Pilopine Hs has four contraindications and must not be administered in the presence of the conditions given in the following table.

Pilopine Hs Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Iritis

Do Not Combine

Miosis disorder

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Pilocarpine may interact with Pulse Frequency

There are 20 known major drug interactions with Pilopine Hs.

Common Pilopine Hs Drug Interactions

Drug Name

Risk Level

Description

Acetaminophen

Major

The metabolism of Acetaminophen can be decreased when combined with Pilocarpine.

Antipyrine

Major

The metabolism of Antipyrine can be decreased when combined with Pilocarpine.

Apremilast

Major

The metabolism of Apremilast can be decreased when combined with Pilocarpine.

Arformoterol

Major

The metabolism of Arformoterol can be decreased when combined with Pilocarpine.

Asunaprevir

Major

The metabolism of Asunaprevir can be decreased when combined with Pilocarpine.

image of a doctor in a lab doing drug, clinical research

Pilopine Hs Novel Uses: Which Conditions Have a Clinical Trial Featuring Pilopine Hs?

Currently, 60 active trials are exploring the potential of Pilopine Hs in ameliorating Dry Mouth, insufficient reduction of intraocular pressure with pilocarpine or beta-blocker monotherapy and Sjögren's Syndrome.

Condition

Clinical Trials

Trial Phases

Presbyopia

8 Actively Recruiting

Not Applicable, Phase 3

Glaucoma

0 Actively Recruiting

Glaucoma, Open-Angle

0 Actively Recruiting

Miosis

0 Actively Recruiting

Glaucoma, Angle-Closure

0 Actively Recruiting

Open Angle Glaucoma

10 Actively Recruiting

Phase 3, Not Applicable, Phase 4

Xerostomia

0 Actively Recruiting

laser eye surgery

0 Actively Recruiting

Glaucoma

0 Actively Recruiting

Ocular Hypertension

10 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Phase 4

Radiotherapy

7 Actively Recruiting

Phase 1, Not Applicable, Phase 3, Phase 2

Pilopine Hs Reviews: What are patients saying about Pilopine Hs?

4.3

Patient Review

12/31/2008

Pilopine Hs for Increased Pressure in Eyes

Pilopine HS and selective laser treatment have been effective in avoiding surgery for me. I hadn't found anything else that worked as well. There is some discomfort when first using it, but it's worth it to be able to see clearly again.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about pilopine hs

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How does pilocarpine work?

"Pilocarpine is a drug that falls into the category of cholinergic agonists. By working to stimulate certain nerves, pilocarpine increases saliva production which makes it easier to speak and swallow."

Answered by AI

What are the side effects of pilocarpine?

"The following are continuing or severe symptoms that should be discussed with a doctor: chest pain, diarrhea, irregular heartbeat, headache, nausea or vomiting, shortness of breath, stomach cramps or pain, and tiredness or weakness."

Answered by AI

How do you use pilocarpine gel?

"Remove the cap from the tube and place it on a clean surface. Gently pull down the lower eyelid to form a pocket for the gel. Gently squeeze the tube and apply a continuous strip of gel into and along the pocket. The strip of gel should be about a half-inch wide."

Answered by AI

What is pilocarpine gel?

"PILOPINE HS is a gel that contains the drug pilocarpine hydrochloride. It is used to lower intraocular pressure. It may be used together with other drugs that are used to lower intraocular pressure, including beta blockers, carbonic anhydrase inhibitors, sympathomimetics, and hyperosmotic agents."

Answered by AI

Clinical Trials for Pilopine Hs

Image of Princess Margaret Cancer Center in Toronto, Canada.

Virtual vs Telephone Education for Breast Cancer

18+
All Sexes
Toronto, Canada

The goal of this clinical trial is to compare whether the use of videoconferencing in breast cancer patients undergoing radiotherapy is better for pre-treatment education than telephone calls. The main question it aims to answer is in breast cancer patient receiving radiotherapy, does videoconferencing, compared to telephone calls for pre-treatment education result in decreased procedural fears and concerns? The investigators hypothesize that the use of videoconferencing for pre-treatment radiotherapy education will decrease breast cancer patients' procedural fears and concerns. Researchers will compare the current standard of care in a 30 minute radiation therapist led pre-treatment education call to the intervention of a 45 minute radiation therapist led videoconferencing call to see if the intervention reduces patient procedural fears and concerns, anxiety levels, and has higher patient satisfaction. Participants will be asked to complete questionnaires at three time points: 1. Baseline - at time of study consent. 2. CT-Simulation - after their radiotherapy CT-Simulation appointment. 3. Day 1 Treatment - after their first day of radiotherapy treatment.

Waitlist Available
Has No Placebo

Princess Margaret Cancer Center

Have you considered Pilopine Hs clinical trials?

We made a collection of clinical trials featuring Pilopine Hs, we think they might fit your search criteria.
Go to Trials

Have you considered Pilopine Hs clinical trials?

We made a collection of clinical trials featuring Pilopine Hs, we think they might fit your search criteria.
Go to Trials

Have you considered Pilopine Hs clinical trials?

We made a collection of clinical trials featuring Pilopine Hs, we think they might fit your search criteria.
Go to Trials